EMD-66435

Single-particle
2.57 Å
EMD-66435
3D View Gallery
Deposition: 30/09/2025
Map released: 18/03/2026
Last modified: 18/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-66435

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9x0j summary report (pdf.gz) Map-9x0j FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

IL-33 and Etokimab fab and Tozorakimab fab ternary complex structure

EMD-66435

Single-particle
2.57 Å
EMD-66435
3D View Gallery
Deposition: 30/09/2025
Map released: 18/03/2026
Last modified: 18/03/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: IL-33 and Etokimab fab and Tozorakimab fab ternary complex structure
Fitted models: 9x0j

Deposition Authors: Wang XQ, Wang Y
Structures of clinical antibodies bound to IL-33 uncover two distinct epitopes underlying differential efficacy.
Chen J, Wang Y, Wang X
(2026) MABs , 18 , 2639673 - 2639673
PUBMED: 41765683
DOI: doi:10.1080/19420862.2026.2639673
ISSN: 1942-0870